Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Smoking and myocardial infarction.

C Wilhelmsson, J A Vedin, D Elmfeldt

    Lancet (London, England)
    |February 22, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Candesartan Cilexetil, a Novel Angiotensin II Antagonist, Provides Dose-dependent Antihypertensive Effect with Maintained Tolerability.

    Blood pressure·2017
    Same author

    Otitis media and the mastoid cell system: a study of men born in 1913 and 1923.

    Acta oto-laryngologica·2011
    Same author

    Health-related quality of life during treatment of elderly patients with hypertension: results from the Study on COgnition and Prognosis in the Elderly (SCOPE).

    Journal of human hypertension·2004
    Same author

    Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study.

    The American journal of gastroenterology·2001
    Same author

    Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group.

    Journal of hypertension·2001
    Same author

    Serotonin 5-HT2A receptor binding in platelets from patients with Alzheimer's disease or vascular dementia.

    International psychogeriatrics·2001

    Smoking is more common in male myocardial infarction patients. Stopping smoking after a heart attack halves recurrence and cardiovascular death rates compared to continuing smokers.

    Area of Science:

    • Cardiology
    • Public Health
    • Epidemiology

    Background:

    • Smoking is a known risk factor for cardiovascular disease.
    • Primary myocardial infarction (heart attack) affects many male patients.
    • The impact of smoking cessation post-myocardial infarction requires further investigation.

    Purpose of the Study:

    • To investigate the smoking prevalence in male patients with primary myocardial infarction.
    • To compare the clinical course and outcomes of patients who stopped smoking versus those who continued after myocardial infarction.

    Main Methods:

    • Analysis of a representative series of male patients diagnosed with primary myocardial infarction.
    • Comparison of smoking prevalence in patients versus general population samples.
    • Assessment of clinical course severity, non-fatal recurrence rates, and cardiovascular mortality rates based on smoking status post-infarction.

    Related Experiment Videos

    Main Results:

    • A higher prevalence of smokers was observed in male myocardial infarction patients compared to general population samples.
    • The difference in smoking prevalence decreased with increasing age.
    • Patients who stopped smoking post-infarction experienced a significantly reduced rate of non-fatal recurrences (P < 0.01) and cardiovascular mortality (P < 0.05) compared to those who continued smoking.

    Conclusions:

    • Smoking cessation after primary myocardial infarction is associated with significantly improved patient outcomes.
    • Male patients experiencing myocardial infarction have a higher prevalence of smoking, highlighting the need for targeted smoking cessation interventions.
    • Stopping smoking post-heart attack dramatically reduces the risk of future cardiac events and mortality.